Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Kalytera Announces Binding Agreement to Acquire Salzman Grou
View:
Post by junior6grinder on May 19, 2020 8:39am

Kalytera Announces Binding Agreement to Acquire Salzman Grou

news just dropped 5 minutes ago - glta
https://www.globenewswire.com/news-release/2020/05/19/2035641/0/en/Kalytera-Announces-Binding-Agreement-to-Acquire-Salzman-Group.html
Comment by Theknocker91 on May 19, 2020 8:42am
No mention of phase 3 for gvhd or a partnership for developing that drug, this is pathetic. Salzman group has already been connected with kaly and this is no different then the stero acquisition
Comment by Whydoyoutroll1 on May 19, 2020 8:45am
did you even read the article? James2.0 over here lol idk why you paid bashers dont get a real career
Comment by Theknocker91 on May 19, 2020 8:49am
Yeah I did read the article. Massive dilution for shareholders with no progression of phase 3 gvhd.
Comment by RoyMax123 on May 19, 2020 8:45am
yup, same sh1t but with different smell
Claritas Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities